Amoneta Diagnostics
PrivateLast Round
Grant
May 30, 2019
Total Funding Raised
$7.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Amoneta Diagnostics is a biotechnology company that develops and commercializes innovative blood-based biomarkers and diagnostic tools for neurodegenerative diseases such as Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amoneta Diagnostics Comparables
Compare Amoneta Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ADmit Therapeutics | 83% | |
| Pre Diagnostics AS | 81% | |
| ALZpath, Inc. | 81% |
Amoneta Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 30, 2019 | ||||
| Grant | Aug 1, 2015 |
Amoneta Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 794% MoM to 1.6K.
- Mar 1, 2026
Monthly visitors grew 65% MoM.
Amoneta Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amoneta Diagnostics's valuation, stock price, and market status.
Is Amoneta Diagnostics a public or private company?
Amoneta Diagnostics is a private company.
What is the current stock price of Amoneta Diagnostics?
Amoneta Diagnostics is a private company with no public stock price. Caplight tracks Amoneta Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Amoneta Diagnostics worth (valuation)?
Valuation information for Amoneta Diagnostics is not publicly available.
Can I buy Amoneta Diagnostics stock?
Amoneta Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amoneta Diagnostics's last funding round?
Amoneta Diagnostics's most recent funding round was Grant on May 30, 2019.
Who are the main investors in Amoneta Diagnostics?
Key investors in Amoneta Diagnostics include Alzheimer's Drug Discovery Foundation.
Will Amoneta Diagnostics IPO soon?
No public IPO plans have been announced for Amoneta Diagnostics.
How can I track Amoneta Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amoneta Diagnostics's secondary market activity and sign up for updates.